MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617060774 A) filed by Cspc Megalith Biopharmaceutical Co. , Ltd. on May 13, 2026, for Mrna Vaccine Against Herpes Zoster And Preparation Method Therefor.
Inventors include Fan, Chao; Su, Xiaoye; Wang, Lingyu; Wei, Lifan; Yang, Sicong; Wu, Leibin; Li, Chunlei; Yang, Hanyu; Dan, Mo; and Zhong, Qiang.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention relates to the field of nucleic acid vaccines, and in particular to an mRNA vaccine against the herpes zoster virus and a preparation method therefor. The main components of the vaccine of the present invention comprise mRNA encoding the varicella zoster virus glycoprotein gE or a variant thereof and a lipid nanoparticle. The glycoprotein gE variant mRNA comprises a coding region encoding a VZV glycoprotein E (gE protein) extracellular domain and transmembrane domain, or a coding region composed of the extracellular domain and the transmembrane domain, and does not encode an intracellular domain of the gE protein; or comprises mRNA encoding VZV gE protein having a mutation site.
Disclaimer: Curated by HT Syndication.
